{
  "biblioSummaryInfoArray": {
    "biblioSummaryInfo": {
      "applicationDate": "2017.07.24",
      "applicationFlag": "",
      "applicationNumber": "10-2017-0093661",
      "claimCount": "2",
      "examinerName": "이정국",
      "finalDisposal": "등록결정(재심사후)",
      "inventionTitle": "c-Myc/Max/DNA 복합체 형성을 억제하는 화합물",
      "inventionTitleEng": "Compounds inhibiting formation of c-Myc/Max/DNA  complex",
      "openDate": "2018.02.07",
      "openNumber": "10-2018-0013739",
      "originalApplicationDate": "",
      "originalApplicationKind": "국내출원/신규",
      "originalApplicationNumber": "",
      "originalExaminationRequestDate": "2017.07.24",
      "originalExaminationRequestFlag": "Y",
      "publicationDate": "2018.07.19",
      "publicationNumber": "",
      "registerDate": "2018.07.12",
      "registerNumber": "10-1879992-0000",
      "registerStatus": "등록",
      "translationSubmitDate": ""
    }
  },
  "ipcInfoArray": {
    "ipcInfo": [
      {
        "ipcDate": "(2006.01.01)",
        "ipcNumber": "C07D 215/36"
      },
      {
        "ipcDate": "(2006.01.01)",
        "ipcNumber": "A61K 31/47"
      }
    ]
  },
  "abstractInfoArray": {
    "abstractInfo": {
      "astrtCont": "본 발명은 c-Myc/Max/DNA 복합체 형성을 억제하는 활성을 갖는 특정 화학구조의 신규 화합물 또는 이의 약학적으로 허용 가능한 염을 제공한다."
    }
  },
  "claims": {
    "application_number": "1020170093661",
    "total_amendments": 3,
    "first_version": {
      "version": 1,
      "receipt_date": "20170724",
      "document_name": "[특허출원]특허출원서",
      "claim_count": 7,
      "claims": [
        {
          "claim_number": 1,
          "claim_type": "independent",
          "change_type": "신규",
          "change_code": "I",
          "text": "하기 화학식 1a 또는 1b의 화합물 또는 이의 약학적으로 허용 가능한 염.\n[화학식 1a]\n[이미지]\n[화학식 1b]\n[이미지]\n상기 화학식 1에서,\nR1a 내지 R1d는 서로 독립적으로 수소, 할로겐, C1-6 알킬, C1-6 할로알킬, C1-6 하이드록시알킬, C1-6 알콕시, C1-6 할로알콕시, C2-10 알케닐, C2-10 할로알케닐, C2-10 알키닐, C2-10 할로알키닐, 수산기, 나이트로, 시아노, C1-6 알콕시카르보닐, 아미노, C1-6 알킬아미노, 다이(Cl-6 알킬)아미노, 아미노(C1-6)알킬, (C1-6)알킬아미노(C1-6)알킬, C1-6 알카노일, C3-7 사이클로알킬, 아릴, 헤테로사이클, 또는 헤테로아릴로, R1a 내지 R1d은 서로 독립적으로 치환되지 않거나 또는 선택적으로 치환될 수 있고,\nR2는 수소, C1-6 알킬, (C1-6)알콕시(C1-6)알킬, C1-6 할로알킬, C1-6 하이드록시알킬, C1-6 알콕시, C1-6 할로알콕시, C2-10 알케닐, C2-10 알케닐 카르복시, C2-10 할로알케닐, C2-10 알키닐, C2-10 할로알키닐, 수산기, 나이트로, 시아노, C1-6 알콕시카르보닐, 아미노, C1-6 알킬아미노, C1-6 시아노알킬, 다이(Cl-6 알킬)아미노, 아미노(C1-6)알킬, (C1-6)알킬아미노(C1-6)알킬, C1-6 알카노일, C3-7 사이클로알킬, (C1-6)알킬(C3-7)사이클로알킬, 아릴, (C1-6)알킬아릴, (C1-6)할로알킬아릴, (C2-6)알케닐아마이드(C1-6)알킬알콕시, 헤테로사이클, (C1-6)알킬헤테로사이클, 헤테로아릴, 또는 (C1-6)알킬헤테로아릴로, R2는 치환되지 않거나 또는 선택적으로 치환될 수 있고, \nR3는 C1-4 알킬, 이소알킬, 사이클로알킬, 페닐, 또는 C1-4 할로알킬이며,\nn은 0 내지 2의 정수이고,\nY는 수소, 알킬, 할로알킬, -C(O)알킬, -C(O)아릴, 설포닐알킬, 설포닐아릴, 아릴, 또는 알킬아릴이며, 여기에서 알킬은 탄소수 1 내지 10, 바람직하게는 탄소수 1 내지 4이고, 아릴은 치환되지 않거나 선택적으로 치환될 수 있음.",
          "refers_to": []
        },
        {
          "claim_number": 2,
          "claim_type": "dependent",
          "change_type": "신규",
          "change_code": "I",
          "text": "제1항에 있어서, 상기 화합물은 화학식 2a 또는 2b의 구조를 갖거나 이의 약학적으로 허용 가능한 염인 화합물.\n[화학식 2a]\n[이미지]\n[화학식 2b]\n[이미지]\n상기 화학식 2에서,\nR1a 내지 R1d, R3, n 및 Y는 화학식 1에서 정의한 바와 같으며, \nm은 0 내지 4의 정수이고,\nR6는 페닐, 옥사졸, 피라졸, 피롤, 이미다졸, 싸이아졸, 싸이오펜, 피리딘, 피리미딘, 퓨란, 인돌, 벤조피라졸, 벤조싸이아졸, 벤조옥사졸, 이소옥사졸, 벤조이미다졸, 1,2,5-옥사다이아졸, 피롤로[2,3-b]피리딘, 또는 벤조싸이오펜이며, 이들은 치환되지 않거나 선택적으로 하나 이상의 수소, C1-6 알킬, C1-6 할로알킬, C1-6 알콕시, 할로겐 또는 하나 이상의 수소, 페닐, 옥사졸, 피라졸, 피롤, 이미다졸, 싸이아졸, 싸이오펜, 피리딘, 피리미딘, 퓨란, 인돌, 벤조피라졸, 벤조싸이아졸, 벤조옥사졸, 이소옥사졸, 벤조이미다졸, 또는 벤조싸이오펜으로 치환 또는 비치환된 페닐로 치환될 수 있음.",
          "refers_to": [
            1
          ]
        },
        {
          "claim_number": 3,
          "claim_type": "dependent",
          "change_type": "신규",
          "change_code": "I",
          "text": "제2항에 있어서, 상기 화합물은 R1a 내지 R1d 중 어느 하나 이상이 할로겐이며, R3가 C1-4 알킬, 이소알킬, 사이클로알킬, 페닐, 또는 C1-4 할로알킬이고, m은 1 또는 2인 것을 특징으로 하는 화합물.",
          "refers_to": [
            2
          ]
        },
        {
          "claim_number": 4,
          "claim_type": "dependent",
          "change_type": "신규",
          "change_code": "I",
          "text": "제1항에 있어서, 상기 화합물은 화학식 3a 또는 3b의 구조를 갖거나 이의 약학적으로 허용 가능한 염인 화합물.\n[화학식 3a]\n[이미지]\n[화학식 3b]\n[이미지]\n상기 화학식 3에서,\nR1a 내지 R1d, R3, 및 n은 화학식 1에서 정의한 바와 같으며, \nR4a 및 R4b는 서로 독립적으로 수소, 할로겐, C1-4 알킬, C1-4 할로알킬, 또는 할로겐 이외의 치환기로 하나 이상의 수소가 치환된 C1-4 알킬이며,\nAr은 페닐, 5 ~ 6원의 헤테로아릴, 또는 8 ~ 12원의 바이헤테로아릴 이고, 상기 헤테로아릴은 고리 내 N, S, 및 O 중 적어도 하나를 1개 이상 포함하며,\n상기 Ar은 치환되지 않거나 선택적으로 하나 이상의 할로겐, C1-6 알킬, C1-6 알킬티오, C1-6 할로알킬, C1-6 할로알킬티오, C1-6 알콕시, C1-6 할로알콕시, C2-10 알케닐, C2-10 할로알케닐, C2-10 알키닐, C2-10 할로알키닐, 수산기, COOH, 나이트로, 시아노, C1-6 알콕시카르보닐, 아미노, C1-6 알킬아미노, 다이(Cl-6 알킬)아미노, 아미노(C1-6)알킬, (C1-6)알킬아미노(C1-6)알킬, (C1-6)알콕시(C1-6)알킬아미노, (C1-6)알킬아미노(C1-6)알킬아미노, C1-6 알카노일, SF5, S(O)CF3, SCF3, NHC(=O)CH3, C(=O)NHCH3, NHSO2CH3 C3-7 사이클로알킬, 아릴, 벤조일, 헤테로사이클, 헤테로아릴, 페닐, 옥사졸, 피라졸, 피롤, 이미다졸, 싸이아졸, 싸이오펜, 피리딘, 피리미딘, 퓨란, 인돌, 벤조피라졸, 벤조싸이아졸, 벤조옥사졸, 이소옥사졸, 벤조이미다졸, 또는 벤조싸이오펜으로 치환될 수 있고,\n상기 Ar의 치환기들은 치환되지 않거나, CF3, 할로겐, C1-3 알킬, C1-3 할로알킬, 수산기, COOH, 나이트로, 시아노, 아미노, 다이(Cl-3 알킬)아미노, NHC(=O)CH3, 및 C(=O)NHCH3 로 이루어진 군으로부터 선택된 하나 이상으로 치환될 수 있음.",
          "refers_to": [
            1
          ]
        },
        {
          "claim_number": 5,
          "claim_type": "dependent",
          "change_type": "신규",
          "change_code": "I",
          "text": "제4항에 있어서, 상기 화합물은 R1a 내지 R1d 중 어느 하나 이상이 할로겐이며, R3가 C1-4 알킬, 이소알킬, 사이클로알킬, 페닐, 또는 C1-4 할로알킬이고, R4a 및 R4b는 서로 독립적으로 C1-4 알킬, 할로겐, 또는 C1-4 사이클로알킬인 것을 특징으로 하는 화합물.",
          "refers_to": [
            4
          ]
        },
        {
          "claim_number": 6,
          "claim_type": "dependent",
          "change_type": "신규",
          "change_code": "I",
          "text": "제1항에 있어서, 상기 화합물은 \n3-acetyl-8-bromo-5-chloro-2-(methylsulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-(methylthio)quinolin-4(1H)-one,\n3-acetyl-2-(benzylthio)-8-bromo-5-chloroquinolin-4(1H)-one,\n3-acetyl-2-(benzylsulfinyl)-8-bromo-5-chloroquinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-1-methyl-2-(methylthio)quinolin-4(1H)-one,\n3-acetyl-5,8-dichloro-2-(methylsulfinyl)quinolin-4(1H)-one,\n3-acetyl-6-fluoro-1-methyl-2-(methylthio)quinolin-4(1H)-one,\n1-(6-fluoro-4-hydroxy-2-(methylthio)quinolin-3-yl)ethan-1-one,\n3-acetyl-8-bromo-1-(4-bromobenzoyl)-5-chloro-2-(methylsulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((4-chlorobenzyl)thio)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((4-chlorobenzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-(phenylthio)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-(phenylsulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((2-methoxyphenyl)thio)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((2-methoxyphenyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-2-((4-bromophenyl)thio)-5-chloroquinolin-4(1H)-one,\n3-acetyl-8-bromo-2-((4-bromophenyl)sulfinyl)-5-chloroquinolin-4(1H)-one,\n1,1'-(8-bromo-5-chloro-2-(methylthio)-4-oxoquinoline-1,3(4H)-diyl)bis(ethan-1-one),\n1,1'-(8-bromo-5-chloro-2-(methylsulfinyl)-4-oxoquinoline-1,3(4H)-diyl)bis(ethan-1-one),\n3-acetyl-2-(benzylsulfinyl)-8-bromo-1-(4-bromobenzoyl)-5-chloroquinolin-4(1H)-one,\n3-acetyl-8-bromo-1-(4-bromobenzoyl)-5-chloro-2-(methylsulfonyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-1-(3-chloro-4-fluorobenzyl)-2-(methylsulfinyl)quinolin-4(1H)-one,\n3-acetyl-2-(benzylthio)-8-bromo-1-(4-bromobenzoyl)-5-chloroquinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-(isopropylthio)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-(isopropylsulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((1-phenylethyl)sulfinyl)quinolin-4(1H)-one,\n3-(((3-acetyl-8-bromo-5-chloro-4-oxo-1,4-dihydroquinolin-2-yl)thio)methyl)benzonitrile,\n3-(((3-acetyl-8-bromo-5-chloro-4-oxo-1,4-dihydroquinolin-2-yl)sulfinyl)methyl)benzonitrile,\n3-acetyl-8-bromo-5-chloro-2-((2,4-difluorobenzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((3-chloro-4-fluorobenzyl)thio)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((3-chloro-4-fluorobenzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((4-nitrobenzyl)thio)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((4-nitrobenzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-2-(benzylsulfonyl)-8-bromo-5-chloroquinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-1-(methylsulfonyl)-2-(methylthio)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-(methylsulfinyl)-1-((trifluoromethyl)sulfonyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-1-((4-chlorophenyl)sulfonyl)-2-(methylthio)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-(methylthio)-1-((4-nitrophenyl)sulfonyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-1-(ethylsulfonyl)-2-(methylsulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-1-((4-(tert-butyl)phenyl)sulfonyl)-5-chloro-2-(methylthio)quinolin-4(1H)-one,\n3-acetyl-8-bromo-1-((4-(tert-butyl)phenyl)sulfonyl)-5-chloro-2-(methylsulfonyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-1-((4-(tert-butyl)phenyl)sulfonyl)-5-chloro-2-(methylsulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((2,5-dichlorobenzyl)thio)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((2,5-dichlorobenzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((3,5-difluorobenzyl)thio)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((3,5-difluorobenzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((3-iodobenzyl)thio)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((3-iodobenzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((3-fluorobenzyl)thio)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((3-fluorobenzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n1-(2-(benzylthio)-8-bromo-5-chloro-4-hydroxyquinolin-3-yl)ethan-1-one,\n1-(2-(benzylsulfinyl)-8-bromo-5-chloro-4-hydroxyquinolin-3-yl)ethan-1-one,\n1-(2-(benzylsulfonyl)-8-bromo-5-chloro-4-hydroxyquinolin-3-yl)ethan-1-one,\n3-acetyl-8-bromo-5-chloro-2-((3-methoxybenzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((4-((trifluoromethyl)thio)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-5,8-dichloro-2-((4-nitrobenzyl)sulfinyl)quinolin-4(1H)-one,\n2-(((3-acetyl-8-bromo-5-chloro-4-oxo-1,4-dihydroquinolin-2-yl)sulfinyl)methyl)benzonitrile,\n3-acetyl-8-bromo-5-chloro-2-((3,5-dimethoxybenzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-2-((4-(tert-butyl)benzyl)sulfinyl)-5-chloroquinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((methoxymethyl)thio)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-mercaptoquinolin-4(1H)-one,\n3-acetyl-2-((4-benzoylbenzyl)sulfinyl)-8-bromo-5-chloroquinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((4-((trifluoromethyl)sulfinyl)benzyl)sulfinyl)quinolin-4(1H)-one,\n2-((3-acetyl-8-bromo-5-chloro-4-oxo-1,4-dihydroquinolin-2-yl)sulfinyl)acetonitrile,\n2-((3-acetyl-8-bromo-5-chloro-4-oxo-1,4-dihydroquinolin-2-yl)thio)acetonitrile,\n(Z)-3-((3-acetyl-8-bromo-5-chloro-4-oxo-1,4-dihydroquinolin-2-yl)thio)acrylic acid,\n3-acetyl-8-bromo-5-chloro-2-((4-(pentafluoro-l6-sulfanyl)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((2-fluoro-4-(pentafluoro-l6-sulfanyl)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((4-(trifluoromethyl)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((4-(trifluoromethoxy)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-(((5-(trifluoromethyl)furan-2-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n4-(((3-acetyl-8-bromo-5-chloro-4-oxo-1,4-dihydroquinolin-2-yl)sulfinyl)methyl)benzonitrile,\n3-acetyl-8-bromo-5-chloro-2-((2-chloro-6-fluorobenzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((2-methoxy-4-(pentafluoro-l6-sulfanyl)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((3-fluoro-5-(pentafluoro-l6-sulfanyl)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((3-(pentafluoro-l6-sulfanyl)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-(((perfluorophenyl)methyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-5,8-dichloro-2-((4-((trifluoromethyl)thio)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-5,8-difluoro-2-((4-(pentafluoro-l6-sulfanyl)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-5,8-difluoro-2-(((5-(trifluoromethyl)furan-2-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-5,8-difluoro-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-5,8-dichloro-2-((4-iodobenzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((pyridin-3-ylmethyl)sulfinyl)quinolin-4(1H)-one,\n5,8-difluoro-3-isobutyryl-2-((4-((trifluoromethyl)thio)benzyl)sulfinyl)quinolin-4(1H)-one,\n5,8-dichloro-3-isobutyryl-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n3-benzoyl-5,8-difluoro-2-((4-(pentafluoro-l6-sulfanyl)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-benzoyl-5,8-dichloro-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\nmethyl 5-(((3-acetyl-5,8-dichloro-4-oxo-1,4-dihydroquinolin-2-yl)sulfinyl)methyl)furan-2-carboxylate,\n2-(((3-acetyl-5,8-dichloro-4-oxo-1,4-dihydroquinolin-2-yl)sulfinyl)methyl)isoindoline-1,3-dione,\nmethyl 4-(((3-acetyl-5,8-dichloro-4-oxo-1,4-dihydroquinolin-2-yl)sulfinyl)methyl)benzoate,\n3-acetyl-5-methoxy-2-((4-(pentafluoro-l6-sulfanyl)benzyl)thio)quinolin-4(1H)-one,\n3-acetyl-5-methoxy-2-((4-(pentafluoro-l6-sulfanyl)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-5-methoxy-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n8-bromo-5-chloro-3-isobutyryl-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n8-bromo-5-chloro-3-(cyclopropanecarbonyl)-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n5,8-dichloro-3-(cyclopropanecarbonyl)-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n5-(((3-acetyl-8-bromo-5-chloro-4-oxo-1,4-dihydroquinolin-2-yl)sulfinyl)methyl)thiophene-2-carbonitrile,\n2-(((6-(1H-pyrazol-1-yl)pyridin-3-yl)methyl)sulfinyl)-3-acetyl-8-bromo-5-chloroquinolin-4(1H)-one,\n3-acetyl-2-(((6-aminopyridin-3-yl)methyl)sulfinyl)-8-bromo-5-chloroquinolin-4(1H)-one,\n8-bromo-5-chloro-3-(cyclopropanecarbonyl)-2-((4-((trifluoromethyl)thio)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-(((2-methyl-6-(trifluoromethyl)pyridin-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\nN-(4-(((3-acetyl-8-bromo-5-chloro-4-oxo-1,4-dihydroquinolin-2-yl)sulfinyl)methyl)phenyl)methanesulfonamide,\n3-acetyl-8-bromo-5-chloro-2-(((6-chloropyridin-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-(((6-((2-methoxyethyl)amino)pyridin-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-(((4-methyl-1,2,5-oxadiazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n2-(((1H-pyrrolo[2,3-b]pyridin-5-yl)methyl)sulfinyl)-3-acetyl-8-bromo-5-chloroquinolin-4(1H)-one,\n또는 이들의 약학적으로 허용 가능한 염인 화합물.",
          "refers_to": [
            1
          ]
        },
        {
          "claim_number": 7,
          "claim_type": "independent",
          "change_type": "신규",
          "change_code": "I",
          "text": "제1항 내지 제6항 중 어느 한 항의 화합물 또는 이의 약학적으로 허용 가능한 염, 및 약학적으로 허용 가능한 담체를 포함하는 조성물.",
          "refers_to": []
        }
      ]
    },
    "last_version": {
      "version": 3,
      "receipt_date": "20180703",
      "document_name": "[명세서등 보정]보정서(재심사)",
      "claim_count": 7,
      "claims": [
        {
          "claim_number": 1,
          "claim_type": "independent",
          "change_type": "삭제",
          "change_code": "D",
          "text": "",
          "refers_to": []
        },
        {
          "claim_number": 2,
          "claim_type": "independent",
          "change_type": "삭제",
          "change_code": "D",
          "text": "",
          "refers_to": []
        },
        {
          "claim_number": 3,
          "claim_type": "independent",
          "change_type": "삭제",
          "change_code": "D",
          "text": "",
          "refers_to": []
        },
        {
          "claim_number": 4,
          "claim_type": "independent",
          "change_type": "수정",
          "change_code": "A",
          "text": "하기 화학식 3a 또는 화학식 3b로 표시되는 화합물 또는 이의 약학적으로 허용 가능한 염. [화학식 3a][화학식 3b]상기 화학식 3a 또는 화학식 3b에서,R1a내지 R1d는 서로 독립적으로 수소, 할로겐, C1-6알킬, C1-6할로알킬, C1-6하이드록시알킬, C1-6알콕시, C1-6할로알콕시, C2-10알케닐, C2-10할로알케닐, C2-10알키닐, C2-10할로알키닐, 수산기, 나이트로, 시아노, C1-6알콕시카르보닐, 아미노, C1-6알킬아미노, 아미노(C1-6)알킬, (C1-6)알킬아미노(C1-6)알킬, C1-6알카노일, C3-7사이클로알킬, 아릴, 헤테로사이클, 또는 헤테로아릴 이고,R3는 C1-4 알킬, 이소알킬, 사이클로알킬, 페닐, 또는 C1-4 할로알킬이며,n은 1 또는 2 이고,R4a 및 R4b는 수소이며,Ar은 5 ~ 6원의 헤테로아릴, 또는 8 ~ 12원의 바이헤테로아릴 이고, 상기 헤테로아릴은 고리 내 N, S, 및 O 중 적어도 하나를 1개 이상 포함하며,상기 Ar은 치환되지 않거나 선택적으로 하나 이상의 할로겐, C1-6 알킬, C1-6 알킬티오, C1-6 할로알킬, C1-6 할로알킬티오, C1-6 알콕시, C1-6 할로알콕시, C2-10 알케닐, C2-10 할로알케닐, C2-10 알키닐, C2-10 할로알키닐, 수산기, COOH, 나이트로, 시아노, C1-6 알콕시카르보닐, 아미노, C1-6 알킬아미노, 다이(Cl-6 알킬)아미노, 아미노(C1-6)알킬, (C1-6)알킬아미노(C1-6)알킬, (C1-6)알콕시(C1-6)알킬아미노, (C1-6)알킬아미노(C1-6)알킬아미노, C1-6 알카노일, SF5, S(O)CF3, SCF3, NHC(=O)CH3, C(=O)NHCH3, NHSO2CH3 C3-7 사이클로알킬, 아릴, 벤조일, 헤테로사이클, 헤테로아릴, 페닐, 옥사졸, 피라졸, 피롤, 이미다졸, 싸이아졸, 싸이오펜, 피리딘, 피리미딘, 퓨란, 인돌, 벤조피라졸, 벤조싸이아졸, 벤조옥사졸, 이소옥사졸, 벤조이미다졸, 또는 벤조싸이오펜으로 치환될 수 있고,상기 Ar의 치환기들은 치환되지 않거나, CF3, 할로겐, C1-3 알킬, C1-3 할로알킬, 수산기, COOH, 나이트로, 시아노, 아미노, 다이(Cl-3 알킬)아미노, NHC(=O)CH3, 및 C(=O)NHCH3 로 이루어진 군으로부터 선택된 하나 이상으로 치환될 수 있음.",
          "refers_to": []
        },
        {
          "claim_number": 5,
          "claim_type": "independent",
          "change_type": "삭제",
          "change_code": "D",
          "text": "",
          "refers_to": []
        },
        {
          "claim_number": 6,
          "claim_type": "dependent",
          "change_type": "수정",
          "change_code": "A",
          "text": "제4항에 있어서, 상기 화합물은3-acetyl-8-bromo-5-chloro-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,3-acetyl-8-bromo-5-chloro-2-(((5-(trifluoromethyl)furan-2-yl)methyl)sulfinyl)quinolin-4(1H)-one,3-acetyl-5,8-difluoro-2-(((5-(trifluoromethyl)furan-2-yl)methyl)sulfinyl)quinolin-4(1H)-one,3-acetyl-5,8-difluoro-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,3-acetyl-8-bromo-5-chloro-2-((pyridin-3-ylmethyl)sulfinyl)quinolin-4(1H)-one,5,8-dichloro-3-isobutyryl-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,3-benzoyl-5,8-dichloro-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,methyl 5-(((3-acetyl-5,8-dichloro-4-oxo-1,4-dihydroquinolin-2-yl)sulfinyl)methyl)furan-2-carboxylate,2-(((3-acetyl-5,8-dichloro-4-oxo-1,4-dihydroquinolin-2-yl)sulfinyl)methyl)isoindoline-1,3-dione,3-acetyl-5-methoxy-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,8-bromo-5-chloro-3-isobutyryl-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,8-bromo-5-chloro-3-(cyclopropanecarbonyl)-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,5,8-dichloro-3-(cyclopropanecarbonyl)-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,5-(((3-acetyl-8-bromo-5-chloro-4-oxo-1,4-dihydroquinolin-2-yl)sulfinyl)methyl)thiophene-2-carbonitrile,2-(((6-(1H-pyrazol-1-yl)pyridin-3-yl)methyl)sulfinyl)-3-acetyl-8-bromo-5-chloroquinolin-4(1H)-one,3-acetyl-2-(((6-aminopyridin-3-yl)methyl)sulfinyl)-8-bromo-5-chloroquinolin-4(1H)-one,3-acetyl-8-bromo-5-chloro-2-(((2-methyl-6-(trifluoromethyl)pyridin-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,3-acetyl-8-bromo-5-chloro-2-(((6-chloropyridin-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,3-acetyl-8-bromo-5-chloro-2-(((6-((2-methoxyethyl)amino)pyridin-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,3-acetyl-8-bromo-5-chloro-2-(((4-methyl-1,2,5-oxadiazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one, 및2-(((1H-pyrrolo[2,3-b]pyridin-5-yl)methyl)sulfinyl)-3-acetyl-8-bromo-5-chloroquinolin-4(1H)-one 으로 이루어지는 군으로부터 선택되는 것을 특징으로 하는 화합물 또는 이의 약학적으로 허용 가능한 염.",
          "refers_to": [
            4
          ]
        },
        {
          "claim_number": 7,
          "claim_type": "independent",
          "change_type": "삭제",
          "change_code": "D",
          "text": "",
          "refers_to": []
        }
      ]
    },
    "all_versions": [
      {
        "version": 1,
        "receipt_date": "20170724",
        "document_name": "[특허출원]특허출원서",
        "claim_count": 7,
        "claims": [
          {
            "claim_number": 1,
            "claim_type": "independent",
            "change_type": "신규",
            "change_code": "I",
            "text": "하기 화학식 1a 또는 1b의 화합물 또는 이의 약학적으로 허용 가능한 염.\n[화학식 1a]\n[이미지]\n[화학식 1b]\n[이미지]\n상기 화학식 1에서,\nR1a 내지 R1d는 서로 독립적으로 수소, 할로겐, C1-6 알킬, C1-6 할로알킬, C1-6 하이드록시알킬, C1-6 알콕시, C1-6 할로알콕시, C2-10 알케닐, C2-10 할로알케닐, C2-10 알키닐, C2-10 할로알키닐, 수산기, 나이트로, 시아노, C1-6 알콕시카르보닐, 아미노, C1-6 알킬아미노, 다이(Cl-6 알킬)아미노, 아미노(C1-6)알킬, (C1-6)알킬아미노(C1-6)알킬, C1-6 알카노일, C3-7 사이클로알킬, 아릴, 헤테로사이클, 또는 헤테로아릴로, R1a 내지 R1d은 서로 독립적으로 치환되지 않거나 또는 선택적으로 치환될 수 있고,\nR2는 수소, C1-6 알킬, (C1-6)알콕시(C1-6)알킬, C1-6 할로알킬, C1-6 하이드록시알킬, C1-6 알콕시, C1-6 할로알콕시, C2-10 알케닐, C2-10 알케닐 카르복시, C2-10 할로알케닐, C2-10 알키닐, C2-10 할로알키닐, 수산기, 나이트로, 시아노, C1-6 알콕시카르보닐, 아미노, C1-6 알킬아미노, C1-6 시아노알킬, 다이(Cl-6 알킬)아미노, 아미노(C1-6)알킬, (C1-6)알킬아미노(C1-6)알킬, C1-6 알카노일, C3-7 사이클로알킬, (C1-6)알킬(C3-7)사이클로알킬, 아릴, (C1-6)알킬아릴, (C1-6)할로알킬아릴, (C2-6)알케닐아마이드(C1-6)알킬알콕시, 헤테로사이클, (C1-6)알킬헤테로사이클, 헤테로아릴, 또는 (C1-6)알킬헤테로아릴로, R2는 치환되지 않거나 또는 선택적으로 치환될 수 있고, \nR3는 C1-4 알킬, 이소알킬, 사이클로알킬, 페닐, 또는 C1-4 할로알킬이며,\nn은 0 내지 2의 정수이고,\nY는 수소, 알킬, 할로알킬, -C(O)알킬, -C(O)아릴, 설포닐알킬, 설포닐아릴, 아릴, 또는 알킬아릴이며, 여기에서 알킬은 탄소수 1 내지 10, 바람직하게는 탄소수 1 내지 4이고, 아릴은 치환되지 않거나 선택적으로 치환될 수 있음.",
            "refers_to": []
          },
          {
            "claim_number": 2,
            "claim_type": "dependent",
            "change_type": "신규",
            "change_code": "I",
            "text": "제1항에 있어서, 상기 화합물은 화학식 2a 또는 2b의 구조를 갖거나 이의 약학적으로 허용 가능한 염인 화합물.\n[화학식 2a]\n[이미지]\n[화학식 2b]\n[이미지]\n상기 화학식 2에서,\nR1a 내지 R1d, R3, n 및 Y는 화학식 1에서 정의한 바와 같으며, \nm은 0 내지 4의 정수이고,\nR6는 페닐, 옥사졸, 피라졸, 피롤, 이미다졸, 싸이아졸, 싸이오펜, 피리딘, 피리미딘, 퓨란, 인돌, 벤조피라졸, 벤조싸이아졸, 벤조옥사졸, 이소옥사졸, 벤조이미다졸, 1,2,5-옥사다이아졸, 피롤로[2,3-b]피리딘, 또는 벤조싸이오펜이며, 이들은 치환되지 않거나 선택적으로 하나 이상의 수소, C1-6 알킬, C1-6 할로알킬, C1-6 알콕시, 할로겐 또는 하나 이상의 수소, 페닐, 옥사졸, 피라졸, 피롤, 이미다졸, 싸이아졸, 싸이오펜, 피리딘, 피리미딘, 퓨란, 인돌, 벤조피라졸, 벤조싸이아졸, 벤조옥사졸, 이소옥사졸, 벤조이미다졸, 또는 벤조싸이오펜으로 치환 또는 비치환된 페닐로 치환될 수 있음.",
            "refers_to": [
              1
            ]
          },
          {
            "claim_number": 3,
            "claim_type": "dependent",
            "change_type": "신규",
            "change_code": "I",
            "text": "제2항에 있어서, 상기 화합물은 R1a 내지 R1d 중 어느 하나 이상이 할로겐이며, R3가 C1-4 알킬, 이소알킬, 사이클로알킬, 페닐, 또는 C1-4 할로알킬이고, m은 1 또는 2인 것을 특징으로 하는 화합물.",
            "refers_to": [
              2
            ]
          },
          {
            "claim_number": 4,
            "claim_type": "dependent",
            "change_type": "신규",
            "change_code": "I",
            "text": "제1항에 있어서, 상기 화합물은 화학식 3a 또는 3b의 구조를 갖거나 이의 약학적으로 허용 가능한 염인 화합물.\n[화학식 3a]\n[이미지]\n[화학식 3b]\n[이미지]\n상기 화학식 3에서,\nR1a 내지 R1d, R3, 및 n은 화학식 1에서 정의한 바와 같으며, \nR4a 및 R4b는 서로 독립적으로 수소, 할로겐, C1-4 알킬, C1-4 할로알킬, 또는 할로겐 이외의 치환기로 하나 이상의 수소가 치환된 C1-4 알킬이며,\nAr은 페닐, 5 ~ 6원의 헤테로아릴, 또는 8 ~ 12원의 바이헤테로아릴 이고, 상기 헤테로아릴은 고리 내 N, S, 및 O 중 적어도 하나를 1개 이상 포함하며,\n상기 Ar은 치환되지 않거나 선택적으로 하나 이상의 할로겐, C1-6 알킬, C1-6 알킬티오, C1-6 할로알킬, C1-6 할로알킬티오, C1-6 알콕시, C1-6 할로알콕시, C2-10 알케닐, C2-10 할로알케닐, C2-10 알키닐, C2-10 할로알키닐, 수산기, COOH, 나이트로, 시아노, C1-6 알콕시카르보닐, 아미노, C1-6 알킬아미노, 다이(Cl-6 알킬)아미노, 아미노(C1-6)알킬, (C1-6)알킬아미노(C1-6)알킬, (C1-6)알콕시(C1-6)알킬아미노, (C1-6)알킬아미노(C1-6)알킬아미노, C1-6 알카노일, SF5, S(O)CF3, SCF3, NHC(=O)CH3, C(=O)NHCH3, NHSO2CH3 C3-7 사이클로알킬, 아릴, 벤조일, 헤테로사이클, 헤테로아릴, 페닐, 옥사졸, 피라졸, 피롤, 이미다졸, 싸이아졸, 싸이오펜, 피리딘, 피리미딘, 퓨란, 인돌, 벤조피라졸, 벤조싸이아졸, 벤조옥사졸, 이소옥사졸, 벤조이미다졸, 또는 벤조싸이오펜으로 치환될 수 있고,\n상기 Ar의 치환기들은 치환되지 않거나, CF3, 할로겐, C1-3 알킬, C1-3 할로알킬, 수산기, COOH, 나이트로, 시아노, 아미노, 다이(Cl-3 알킬)아미노, NHC(=O)CH3, 및 C(=O)NHCH3 로 이루어진 군으로부터 선택된 하나 이상으로 치환될 수 있음.",
            "refers_to": [
              1
            ]
          },
          {
            "claim_number": 5,
            "claim_type": "dependent",
            "change_type": "신규",
            "change_code": "I",
            "text": "제4항에 있어서, 상기 화합물은 R1a 내지 R1d 중 어느 하나 이상이 할로겐이며, R3가 C1-4 알킬, 이소알킬, 사이클로알킬, 페닐, 또는 C1-4 할로알킬이고, R4a 및 R4b는 서로 독립적으로 C1-4 알킬, 할로겐, 또는 C1-4 사이클로알킬인 것을 특징으로 하는 화합물.",
            "refers_to": [
              4
            ]
          },
          {
            "claim_number": 6,
            "claim_type": "dependent",
            "change_type": "신규",
            "change_code": "I",
            "text": "제1항에 있어서, 상기 화합물은 \n3-acetyl-8-bromo-5-chloro-2-(methylsulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-(methylthio)quinolin-4(1H)-one,\n3-acetyl-2-(benzylthio)-8-bromo-5-chloroquinolin-4(1H)-one,\n3-acetyl-2-(benzylsulfinyl)-8-bromo-5-chloroquinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-1-methyl-2-(methylthio)quinolin-4(1H)-one,\n3-acetyl-5,8-dichloro-2-(methylsulfinyl)quinolin-4(1H)-one,\n3-acetyl-6-fluoro-1-methyl-2-(methylthio)quinolin-4(1H)-one,\n1-(6-fluoro-4-hydroxy-2-(methylthio)quinolin-3-yl)ethan-1-one,\n3-acetyl-8-bromo-1-(4-bromobenzoyl)-5-chloro-2-(methylsulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((4-chlorobenzyl)thio)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((4-chlorobenzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-(phenylthio)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-(phenylsulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((2-methoxyphenyl)thio)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((2-methoxyphenyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-2-((4-bromophenyl)thio)-5-chloroquinolin-4(1H)-one,\n3-acetyl-8-bromo-2-((4-bromophenyl)sulfinyl)-5-chloroquinolin-4(1H)-one,\n1,1'-(8-bromo-5-chloro-2-(methylthio)-4-oxoquinoline-1,3(4H)-diyl)bis(ethan-1-one),\n1,1'-(8-bromo-5-chloro-2-(methylsulfinyl)-4-oxoquinoline-1,3(4H)-diyl)bis(ethan-1-one),\n3-acetyl-2-(benzylsulfinyl)-8-bromo-1-(4-bromobenzoyl)-5-chloroquinolin-4(1H)-one,\n3-acetyl-8-bromo-1-(4-bromobenzoyl)-5-chloro-2-(methylsulfonyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-1-(3-chloro-4-fluorobenzyl)-2-(methylsulfinyl)quinolin-4(1H)-one,\n3-acetyl-2-(benzylthio)-8-bromo-1-(4-bromobenzoyl)-5-chloroquinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-(isopropylthio)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-(isopropylsulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((1-phenylethyl)sulfinyl)quinolin-4(1H)-one,\n3-(((3-acetyl-8-bromo-5-chloro-4-oxo-1,4-dihydroquinolin-2-yl)thio)methyl)benzonitrile,\n3-(((3-acetyl-8-bromo-5-chloro-4-oxo-1,4-dihydroquinolin-2-yl)sulfinyl)methyl)benzonitrile,\n3-acetyl-8-bromo-5-chloro-2-((2,4-difluorobenzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((3-chloro-4-fluorobenzyl)thio)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((3-chloro-4-fluorobenzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((4-nitrobenzyl)thio)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((4-nitrobenzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-2-(benzylsulfonyl)-8-bromo-5-chloroquinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-1-(methylsulfonyl)-2-(methylthio)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-(methylsulfinyl)-1-((trifluoromethyl)sulfonyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-1-((4-chlorophenyl)sulfonyl)-2-(methylthio)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-(methylthio)-1-((4-nitrophenyl)sulfonyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-1-(ethylsulfonyl)-2-(methylsulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-1-((4-(tert-butyl)phenyl)sulfonyl)-5-chloro-2-(methylthio)quinolin-4(1H)-one,\n3-acetyl-8-bromo-1-((4-(tert-butyl)phenyl)sulfonyl)-5-chloro-2-(methylsulfonyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-1-((4-(tert-butyl)phenyl)sulfonyl)-5-chloro-2-(methylsulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((2,5-dichlorobenzyl)thio)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((2,5-dichlorobenzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((3,5-difluorobenzyl)thio)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((3,5-difluorobenzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((3-iodobenzyl)thio)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((3-iodobenzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((3-fluorobenzyl)thio)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((3-fluorobenzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n1-(2-(benzylthio)-8-bromo-5-chloro-4-hydroxyquinolin-3-yl)ethan-1-one,\n1-(2-(benzylsulfinyl)-8-bromo-5-chloro-4-hydroxyquinolin-3-yl)ethan-1-one,\n1-(2-(benzylsulfonyl)-8-bromo-5-chloro-4-hydroxyquinolin-3-yl)ethan-1-one,\n3-acetyl-8-bromo-5-chloro-2-((3-methoxybenzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((4-((trifluoromethyl)thio)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-5,8-dichloro-2-((4-nitrobenzyl)sulfinyl)quinolin-4(1H)-one,\n2-(((3-acetyl-8-bromo-5-chloro-4-oxo-1,4-dihydroquinolin-2-yl)sulfinyl)methyl)benzonitrile,\n3-acetyl-8-bromo-5-chloro-2-((3,5-dimethoxybenzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-2-((4-(tert-butyl)benzyl)sulfinyl)-5-chloroquinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((methoxymethyl)thio)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-mercaptoquinolin-4(1H)-one,\n3-acetyl-2-((4-benzoylbenzyl)sulfinyl)-8-bromo-5-chloroquinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((4-((trifluoromethyl)sulfinyl)benzyl)sulfinyl)quinolin-4(1H)-one,\n2-((3-acetyl-8-bromo-5-chloro-4-oxo-1,4-dihydroquinolin-2-yl)sulfinyl)acetonitrile,\n2-((3-acetyl-8-bromo-5-chloro-4-oxo-1,4-dihydroquinolin-2-yl)thio)acetonitrile,\n(Z)-3-((3-acetyl-8-bromo-5-chloro-4-oxo-1,4-dihydroquinolin-2-yl)thio)acrylic acid,\n3-acetyl-8-bromo-5-chloro-2-((4-(pentafluoro-l6-sulfanyl)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((2-fluoro-4-(pentafluoro-l6-sulfanyl)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((4-(trifluoromethyl)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((4-(trifluoromethoxy)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-(((5-(trifluoromethyl)furan-2-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n4-(((3-acetyl-8-bromo-5-chloro-4-oxo-1,4-dihydroquinolin-2-yl)sulfinyl)methyl)benzonitrile,\n3-acetyl-8-bromo-5-chloro-2-((2-chloro-6-fluorobenzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((2-methoxy-4-(pentafluoro-l6-sulfanyl)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((3-fluoro-5-(pentafluoro-l6-sulfanyl)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((3-(pentafluoro-l6-sulfanyl)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-(((perfluorophenyl)methyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-5,8-dichloro-2-((4-((trifluoromethyl)thio)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-5,8-difluoro-2-((4-(pentafluoro-l6-sulfanyl)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-5,8-difluoro-2-(((5-(trifluoromethyl)furan-2-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-5,8-difluoro-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-5,8-dichloro-2-((4-iodobenzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((pyridin-3-ylmethyl)sulfinyl)quinolin-4(1H)-one,\n5,8-difluoro-3-isobutyryl-2-((4-((trifluoromethyl)thio)benzyl)sulfinyl)quinolin-4(1H)-one,\n5,8-dichloro-3-isobutyryl-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n3-benzoyl-5,8-difluoro-2-((4-(pentafluoro-l6-sulfanyl)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-benzoyl-5,8-dichloro-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\nmethyl 5-(((3-acetyl-5,8-dichloro-4-oxo-1,4-dihydroquinolin-2-yl)sulfinyl)methyl)furan-2-carboxylate,\n2-(((3-acetyl-5,8-dichloro-4-oxo-1,4-dihydroquinolin-2-yl)sulfinyl)methyl)isoindoline-1,3-dione,\nmethyl 4-(((3-acetyl-5,8-dichloro-4-oxo-1,4-dihydroquinolin-2-yl)sulfinyl)methyl)benzoate,\n3-acetyl-5-methoxy-2-((4-(pentafluoro-l6-sulfanyl)benzyl)thio)quinolin-4(1H)-one,\n3-acetyl-5-methoxy-2-((4-(pentafluoro-l6-sulfanyl)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-5-methoxy-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n8-bromo-5-chloro-3-isobutyryl-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n8-bromo-5-chloro-3-(cyclopropanecarbonyl)-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n5,8-dichloro-3-(cyclopropanecarbonyl)-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n5-(((3-acetyl-8-bromo-5-chloro-4-oxo-1,4-dihydroquinolin-2-yl)sulfinyl)methyl)thiophene-2-carbonitrile,\n2-(((6-(1H-pyrazol-1-yl)pyridin-3-yl)methyl)sulfinyl)-3-acetyl-8-bromo-5-chloroquinolin-4(1H)-one,\n3-acetyl-2-(((6-aminopyridin-3-yl)methyl)sulfinyl)-8-bromo-5-chloroquinolin-4(1H)-one,\n8-bromo-5-chloro-3-(cyclopropanecarbonyl)-2-((4-((trifluoromethyl)thio)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-(((2-methyl-6-(trifluoromethyl)pyridin-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\nN-(4-(((3-acetyl-8-bromo-5-chloro-4-oxo-1,4-dihydroquinolin-2-yl)sulfinyl)methyl)phenyl)methanesulfonamide,\n3-acetyl-8-bromo-5-chloro-2-(((6-chloropyridin-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-(((6-((2-methoxyethyl)amino)pyridin-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-(((4-methyl-1,2,5-oxadiazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n2-(((1H-pyrrolo[2,3-b]pyridin-5-yl)methyl)sulfinyl)-3-acetyl-8-bromo-5-chloroquinolin-4(1H)-one,\n또는 이들의 약학적으로 허용 가능한 염인 화합물.",
            "refers_to": [
              1
            ]
          },
          {
            "claim_number": 7,
            "claim_type": "independent",
            "change_type": "신규",
            "change_code": "I",
            "text": "제1항 내지 제6항 중 어느 한 항의 화합물 또는 이의 약학적으로 허용 가능한 염, 및 약학적으로 허용 가능한 담체를 포함하는 조성물.",
            "refers_to": []
          }
        ]
      },
      {
        "version": 2,
        "receipt_date": "20180423",
        "document_name": "[명세서등 보정]보정서",
        "claim_count": 7,
        "claims": [
          {
            "claim_number": 1,
            "claim_type": "independent",
            "change_type": "삭제",
            "change_code": "D",
            "text": "",
            "refers_to": []
          },
          {
            "claim_number": 2,
            "claim_type": "independent",
            "change_type": "삭제",
            "change_code": "D",
            "text": "",
            "refers_to": []
          },
          {
            "claim_number": 3,
            "claim_type": "independent",
            "change_type": "삭제",
            "change_code": "D",
            "text": "",
            "refers_to": []
          },
          {
            "claim_number": 4,
            "claim_type": "independent",
            "change_type": "수정",
            "change_code": "A",
            "text": "하기 화학식 3a 또는 화학식 3b로 표시되는 화합물 또는 이의 약학적으로 허용 가능한 염. \n[화학식 3a]\n[이미지]\n[화학식 3b]\n[이미지]\n상기 화학식 3a 또는 화학식 3b에서,\nR1a내지 R1d는 서로 독립적으로 수소, 할로겐, C1-6알킬, C1-6할로알킬, C1-6하이드록시알킬, C1-6알콕시, C1-6할로알콕시, C2-10알케닐, C2-10할로알케닐, C2-10알키닐, C2-10할로알키닐, 수산기, 나이트로, 시아노, C1-6알콕시카르보닐, 아미노, C1-6알킬아미노, 아미노(C1-6)알킬, (C1-6)알킬아미노(C1-6)알킬, C1-6알카노일, C3-7사이클로알킬, 아릴, 헤테로사이클, 또는 헤테로아릴 이고,\nR3는 C1-4 알킬, 이소알킬, 사이클로알킬, 페닐, 또는 C1-4 할로알킬이며,\nn은 1 또는 2 이고,\nR4a 및 R4b는 서로 독립적으로 수소, 할로겐, C1-4 알킬, C1-4 할로알킬, 또는 할로겐 이외의 치환기로 하나 이상의 수소가 치환된 C1-4 알킬이며,\nAr은 페닐, 5 ~ 6원의 헤테로아릴, 또는 8 ~ 12원의 바이헤테로아릴 이고, 상기 헤테로아릴은 고리 내 N, S, 및 O 중 적어도 하나를 1개 이상 포함하며,\n상기 Ar은 치환되지 않거나 선택적으로 하나 이상의 할로겐, C1-6 알킬, C1-6 알킬티오, C1-6 할로알킬, C1-6 할로알킬티오, C1-6 알콕시, C1-6 할로알콕시, C2-10 알케닐, C2-10 할로알케닐, C2-10 알키닐, C2-10 할로알키닐, 수산기, COOH, 나이트로, 시아노, C1-6 알콕시카르보닐, 아미노, C1-6 알킬아미노, 다이(Cl-6 알킬)아미노, 아미노(C1-6)알킬, (C1-6)알킬아미노(C1-6)알킬, (C1-6)알콕시(C1-6)알킬아미노, (C1-6)알킬아미노(C1-6)알킬아미노, C1-6 알카노일, SF5, S(O)CF3, SCF3, NHC(=O)CH3, C(=O)NHCH3, NHSO2CH3 C3-7 사이클로알킬, 아릴, 벤조일, 헤테로사이클, 헤테로아릴, 페닐, 옥사졸, 피라졸, 피롤, 이미다졸, 싸이아졸, 싸이오펜, 피리딘, 피리미딘, 퓨란, 인돌, 벤조피라졸, 벤조싸이아졸, 벤조옥사졸, 이소옥사졸, 벤조이미다졸, 또는 벤조싸이오펜으로 치환될 수 있고,\n상기 Ar의 치환기들은 치환되지 않거나, CF3, 할로겐, C1-3 알킬, C1-3 할로알킬, 수산기, COOH, 나이트로, 시아노, 아미노, 다이(Cl-3 알킬)아미노, NHC(=O)CH3, 및 C(=O)NHCH3 로 이루어진 군으로부터 선택된 하나 이상으로 치환될 수 있음.",
            "refers_to": []
          },
          {
            "claim_number": 5,
            "claim_type": "independent",
            "change_type": "삭제",
            "change_code": "D",
            "text": "",
            "refers_to": []
          },
          {
            "claim_number": 6,
            "claim_type": "dependent",
            "change_type": "수정",
            "change_code": "A",
            "text": "제4항에 있어서, 상기 화합물은\n3-acetyl-2-(benzylsulfinyl)-8-bromo-5-chloroquinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((4-chlorobenzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((1-phenylethyl)sulfinyl)quinolin-4(1H)-one,\n3-(((3-acetyl-8-bromo-5-chloro-4-oxo-1,4-dihydroquinolin-2-yl)sulfinyl)methyl)benzonitrile,\n3-acetyl-8-bromo-5-chloro-2-((2,4-difluorobenzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((3-chloro-4-fluorobenzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((4-nitrobenzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-2-(benzylsulfonyl)-8-bromo-5-chloroquinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((2,5-dichlorobenzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((3,5-difluorobenzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((3-iodobenzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((3-fluorobenzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n1-(2-(benzylsulfinyl)-8-bromo-5-chloro-4-hydroxyquinolin-3-yl)ethan-1-one,\n1-(2-(benzylsulfonyl)-8-bromo-5-chloro-4-hydroxyquinolin-3-yl)ethan-1-one,\n3-acetyl-8-bromo-5-chloro-2-((3-methoxybenzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((4-((trifluoromethyl)thio)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-5,8-dichloro-2-((4-nitrobenzyl)sulfinyl)quinolin-4(1H)-one,\n2-(((3-acetyl-8-bromo-5-chloro-4-oxo-1,4-dihydroquinolin-2-yl)sulfinyl)methyl)benzonitrile,\n3-acetyl-8-bromo-5-chloro-2-((3,5-dimethoxybenzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-2-((4-(tert-butyl)benzyl)sulfinyl)-5-chloroquinolin-4(1H)-one,\n3-acetyl-2-((4-benzoylbenzyl)sulfinyl)-8-bromo-5-chloroquinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((4-((trifluoromethyl)sulfinyl)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((4-(pentafluoro-l6-sulfanyl)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((2-fluoro-4-(pentafluoro-l6-sulfanyl)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((4-(trifluoromethyl)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((4-(trifluoromethoxy)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-(((5-(trifluoromethyl)furan-2-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n4-(((3-acetyl-8-bromo-5-chloro-4-oxo-1,4-dihydroquinolin-2-yl)sulfinyl)methyl)benzonitrile,\n3-acetyl-8-bromo-5-chloro-2-((2-chloro-6-fluorobenzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((2-methoxy-4-(pentafluoro-l6-sulfanyl)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((3-fluoro-5-(pentafluoro-l6-sulfanyl)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((3-(pentafluoro-l6-sulfanyl)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-(((perfluorophenyl)methyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-5,8-dichloro-2-((4-((trifluoromethyl)thio)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-5,8-difluoro-2-((4-(pentafluoro-l6-sulfanyl)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-5,8-difluoro-2-(((5-(trifluoromethyl)furan-2-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-5,8-difluoro-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-5,8-dichloro-2-((4-iodobenzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((pyridin-3-ylmethyl)sulfinyl)quinolin-4(1H)-one,\n5,8-difluoro-3-isobutyryl-2-((4-((trifluoromethyl)thio)benzyl)sulfinyl)quinolin-4(1H)-one,\n5,8-dichloro-3-isobutyryl-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n3-benzoyl-5,8-difluoro-2-((4-(pentafluoro-l6-sulfanyl)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-benzoyl-5,8-dichloro-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\nmethyl 5-(((3-acetyl-5,8-dichloro-4-oxo-1,4-dihydroquinolin-2-yl)sulfinyl)methyl)furan-2-carboxylate,\n2-(((3-acetyl-5,8-dichloro-4-oxo-1,4-dihydroquinolin-2-yl)sulfinyl)methyl)isoindoline-1,3-dione,\nmethyl 4-(((3-acetyl-5,8-dichloro-4-oxo-1,4-dihydroquinolin-2-yl)sulfinyl)methyl)benzoate,\n3-acetyl-5-methoxy-2-((4-(pentafluoro-l6-sulfanyl)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-5-methoxy-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n8-bromo-5-chloro-3-isobutyryl-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n8-bromo-5-chloro-3-(cyclopropanecarbonyl)-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n5,8-dichloro-3-(cyclopropanecarbonyl)-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n5-(((3-acetyl-8-bromo-5-chloro-4-oxo-1,4-dihydroquinolin-2-yl)sulfinyl)methyl)thiophene-2-carbonitrile,\n2-(((6-(1H-pyrazol-1-yl)pyridin-3-yl)methyl)sulfinyl)-3-acetyl-8-bromo-5-chloroquinolin-4(1H)-one,\n3-acetyl-2-(((6-aminopyridin-3-yl)methyl)sulfinyl)-8-bromo-5-chloroquinolin-4(1H)-one,\n8-bromo-5-chloro-3-(cyclopropanecarbonyl)-2-((4-((trifluoromethyl)thio)benzyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-(((2-methyl-6-(trifluoromethyl)pyridin-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\nN-(4-(((3-acetyl-8-bromo-5-chloro-4-oxo-1,4-dihydroquinolin-2-yl)sulfinyl)methyl)phenyl)methanesulfonamide,\n3-acetyl-8-bromo-5-chloro-2-(((6-chloropyridin-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-(((6-((2-methoxyethyl)amino)pyridin-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-(((4-methyl-1,2,5-oxadiazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one, 및\n2-(((1H-pyrrolo[2,3-b]pyridin-5-yl)methyl)sulfinyl)-3-acetyl-8-bromo-5-chloroquinolin-4(1H)-one \n로 이루어지는 군으로부터 선택되는 것을 특징으로 하는 화합물 또는 이의 약학적으로 허용 가능한 염.",
            "refers_to": [
              4
            ]
          },
          {
            "claim_number": 7,
            "claim_type": "independent",
            "change_type": "삭제",
            "change_code": "D",
            "text": "",
            "refers_to": []
          }
        ]
      },
      {
        "version": 3,
        "receipt_date": "20180703",
        "document_name": "[명세서등 보정]보정서(재심사)",
        "claim_count": 2,
        "claims": [
          {
            "claim_number": 4,
            "claim_type": "independent",
            "change_type": "수정",
            "change_code": "A",
            "text": "하기 화학식 3a 또는 화학식 3b로 표시되는 화합물 또는 이의 약학적으로 허용 가능한 염. \n[화학식 3a]\n[이미지]\n[화학식 3b]\n[이미지]\n상기 화학식 3a 또는 화학식 3b에서,\nR1a내지 R1d는 서로 독립적으로 수소, 할로겐, C1-6알킬, C1-6할로알킬, C1-6하이드록시알킬, C1-6알콕시, C1-6할로알콕시, C2-10알케닐, C2-10할로알케닐, C2-10알키닐, C2-10할로알키닐, 수산기, 나이트로, 시아노, C1-6알콕시카르보닐, 아미노, C1-6알킬아미노, 아미노(C1-6)알킬, (C1-6)알킬아미노(C1-6)알킬, C1-6알카노일, C3-7사이클로알킬, 아릴, 헤테로사이클, 또는 헤테로아릴 이고,\nR3는 C1-4 알킬, 이소알킬, 사이클로알킬, 페닐, 또는 C1-4 할로알킬이며,\nn은 1 또는 2 이고,\nR4a 및 R4b는 수소이며,\nAr은 5 ~ 6원의 헤테로아릴, 또는 8 ~ 12원의 바이헤테로아릴 이고, 상기 헤테로아릴은 고리 내 N, S, 및 O 중 적어도 하나를 1개 이상 포함하며,\n상기 Ar은 치환되지 않거나 선택적으로 하나 이상의 할로겐, C1-6 알킬, C1-6 알킬티오, C1-6 할로알킬, C1-6 할로알킬티오, C1-6 알콕시, C1-6 할로알콕시, C2-10 알케닐, C2-10 할로알케닐, C2-10 알키닐, C2-10 할로알키닐, 수산기, COOH, 나이트로, 시아노, C1-6 알콕시카르보닐, 아미노, C1-6 알킬아미노, 다이(Cl-6 알킬)아미노, 아미노(C1-6)알킬, (C1-6)알킬아미노(C1-6)알킬, (C1-6)알콕시(C1-6)알킬아미노, (C1-6)알킬아미노(C1-6)알킬아미노, C1-6 알카노일, SF5, S(O)CF3, SCF3, NHC(=O)CH3, C(=O)NHCH3, NHSO2CH3 C3-7 사이클로알킬, 아릴, 벤조일, 헤테로사이클, 헤테로아릴, 페닐, 옥사졸, 피라졸, 피롤, 이미다졸, 싸이아졸, 싸이오펜, 피리딘, 피리미딘, 퓨란, 인돌, 벤조피라졸, 벤조싸이아졸, 벤조옥사졸, 이소옥사졸, 벤조이미다졸, 또는 벤조싸이오펜으로 치환될 수 있고,\n상기 Ar의 치환기들은 치환되지 않거나, CF3, 할로겐, C1-3 알킬, C1-3 할로알킬, 수산기, COOH, 나이트로, 시아노, 아미노, 다이(Cl-3 알킬)아미노, NHC(=O)CH3, 및 C(=O)NHCH3 로 이루어진 군으로부터 선택된 하나 이상으로 치환될 수 있음.",
            "refers_to": []
          },
          {
            "claim_number": 6,
            "claim_type": "dependent",
            "change_type": "수정",
            "change_code": "A",
            "text": "제4항에 있어서, 상기 화합물은\n3-acetyl-8-bromo-5-chloro-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-(((5-(trifluoromethyl)furan-2-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-5,8-difluoro-2-(((5-(trifluoromethyl)furan-2-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-5,8-difluoro-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-((pyridin-3-ylmethyl)sulfinyl)quinolin-4(1H)-one,\n5,8-dichloro-3-isobutyryl-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n3-benzoyl-5,8-dichloro-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\nmethyl 5-(((3-acetyl-5,8-dichloro-4-oxo-1,4-dihydroquinolin-2-yl)sulfinyl)methyl)furan-2-carboxylate,\n2-(((3-acetyl-5,8-dichloro-4-oxo-1,4-dihydroquinolin-2-yl)sulfinyl)methyl)isoindoline-1,3-dione,\n3-acetyl-5-methoxy-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n8-bromo-5-chloro-3-isobutyryl-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n8-bromo-5-chloro-3-(cyclopropanecarbonyl)-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n5,8-dichloro-3-(cyclopropanecarbonyl)-2-(((5-methylisoxazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n5-(((3-acetyl-8-bromo-5-chloro-4-oxo-1,4-dihydroquinolin-2-yl)sulfinyl)methyl)thiophene-2-carbonitrile,\n2-(((6-(1H-pyrazol-1-yl)pyridin-3-yl)methyl)sulfinyl)-3-acetyl-8-bromo-5-chloroquinolin-4(1H)-one,\n3-acetyl-2-(((6-aminopyridin-3-yl)methyl)sulfinyl)-8-bromo-5-chloroquinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-(((2-methyl-6-(trifluoromethyl)pyridin-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-(((6-chloropyridin-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-(((6-((2-methoxyethyl)amino)pyridin-3-yl)methyl)sulfinyl)quinolin-4(1H)-one,\n3-acetyl-8-bromo-5-chloro-2-(((4-methyl-1,2,5-oxadiazol-3-yl)methyl)sulfinyl)quinolin-4(1H)-one, 및\n2-(((1H-pyrrolo[2,3-b]pyridin-5-yl)methyl)sulfinyl)-3-acetyl-8-bromo-5-chloroquinolin-4(1H)-one \n으로 이루어지는 군으로부터 선택되는 것을 특징으로 하는 화합물 또는 이의 약학적으로 허용 가능한 염.",
            "refers_to": [
              4
            ]
          }
        ]
      }
    ],
    "summary": {
      "before_claim_count": 7,
      "after_claim_count": 2,
      "total_versions": 3
    }
  },
  "familyInfoArray": {
    "familyInfo": ""
  },
  "internationalInfoArray": {
    "internationalInfo": {
      "internationOpenDate": "",
      "internationOpenNumber": "",
      "internationalApplicationDate": "",
      "internationalApplicationNumber": ""
    }
  },
  "applicantInfoArray": {
    "applicantInfo": [
      {
        "address": "경기도 고양시 일산동구...",
        "code": "120000367866",
        "country": "대한민국",
        "engName": "NATIONAL CANCER CENTER",
        "name": "국립암센터"
      },
      {
        "address": "대전광역시 유성구...",
        "code": "319980077651",
        "country": "대한민국",
        "engName": "KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY",
        "name": "한국화학연구원"
      }
    ]
  },
  "inventorInfoArray": {
    "inventorInfo": [
      {
        "address": "경기도 고양시 일산동구...",
        "code": "",
        "country": "대한민국",
        "engName": "JEONG, Kyung Chae",
        "name": "정경채"
      },
      {
        "address": "대전광역시 유성구...",
        "code": "",
        "country": "대한민국",
        "engName": "LIM, Hwan Jung",
        "name": "임환정"
      },
      {
        "address": "대전광역시 유성구...",
        "code": "",
        "country": "대한민국",
        "engName": "PARK, Seong Jun",
        "name": "박성준"
      },
      {
        "address": "경기도 파주시 책향기로 ***, **...",
        "code": "",
        "country": "대한민국",
        "engName": "SEO, Ho Kyung",
        "name": "서호경"
      },
      {
        "address": "경기도 군포시 용호*로 **, *...",
        "code": "",
        "country": "대한민국",
        "engName": "AHN, Kyung Ohk",
        "name": "안경옥"
      },
      {
        "address": "경기도 파주시 미래로 ***, ***동 ...",
        "code": "",
        "country": "대한민국",
        "engName": "LEE, Sang Jin",
        "name": "이상진"
      },
      {
        "address": "경기도 과천시 별양로 ***,...",
        "code": "",
        "country": "대한민국",
        "engName": "LEE, Eun Sook",
        "name": "이은숙"
      }
    ]
  },
  "agentInfoArray": {
    "agentInfo": {
      "address": "서울특별시 강남구 테헤란로 ***, **층 (삼성동,본솔빌딩)(명진국제특허법률사무소)",
      "code": "920030002203",
      "country": "대한민국",
      "engName": "Lee, Myoung-Jin",
      "name": "이명진"
    }
  },
  "priorityInfoArray": {
    "priorityInfo": {
      "priorityApplicationCountry": "대한민국",
      "priorityApplicationDate": "2016.07.29",
      "priorityApplicationNumber": "1020160097429"
    }
  },
  "designatedStateInfoArray": "",
  "priorArtDocumentsInfoArray": {
    "priorArtDocumentsInfo": {
      "documentsNumber": "KR100574351 B1",
      "examinerQuotationFlag": "Y"
    }
  },
  "legalStatusInfoArray": {
    "legalStatusInfo": [
      {
        "commonCodeName": "수리 (Accepted)",
        "documentEngName": "[Patent Application] Patent Application",
        "documentName": "[특허출원]특허출원서",
        "receiptDate": "2017.07.24",
        "receiptNumber": "1-1-2017-0710425-90"
      },
      {
        "commonCodeName": "수리 (Accepted)",
        "documentEngName": "[Amendment to Patent Application, etc.] Amendment",
        "documentName": "[출원서등 보정]보정서",
        "receiptDate": "2017.07.27",
        "receiptNumber": "1-1-2017-0725176-66"
      },
      {
        "commonCodeName": "발송처리완료 (Completion of Transmission)",
        "documentEngName": "Request for Amendment",
        "documentName": "보정요구서",
        "receiptDate": "2017.08.02",
        "receiptNumber": "1-5-2017-0107019-71"
      },
      {
        "commonCodeName": "수리 (Accepted)",
        "documentEngName": "[Amendment to Patent Application, etc.] Amendment",
        "documentName": "[출원서등 보정]보정서",
        "receiptDate": "2017.08.08",
        "receiptNumber": "1-1-2017-0765461-01"
      },
      {
        "commonCodeName": "수리 (Accepted)",
        "documentEngName": "Notification of change of applicant's information",
        "documentName": "출원인정보변경(경정)신고서",
        "receiptDate": "2017.09.14",
        "receiptNumber": "4-1-2017-5149265-52"
      },
      {
        "commonCodeName": "수리 (Accepted)",
        "documentEngName": "Notification of change of applicant's information",
        "documentName": "출원인정보변경(경정)신고서",
        "receiptDate": "2017.09.14",
        "receiptNumber": "4-1-2017-5149242-13"
      },
      {
        "commonCodeName": "수리 (Accepted)",
        "documentEngName": "[Request for Preferential Examination] Request for Examination (Request for Preferential Examination)",
        "documentName": "[우선심사신청]심사청구(우선심사신청)서",
        "receiptDate": "2017.11.24",
        "receiptNumber": "1-1-2017-1174778-96"
      },
      {
        "commonCodeName": "수리 (Accepted)",
        "documentEngName": "[Request for Preferential Examination] Request for Prior Art Search",
        "documentName": "[우선심사신청]선행기술조사의뢰서",
        "receiptDate": "2017.11.27",
        "receiptNumber": "9-1-9999-9999999-89"
      },
      {
        "commonCodeName": "수리 (Accepted)",
        "documentEngName": "[Request for Preferential Examination] Report of Prior Art Search",
        "documentName": "[우선심사신청]선행기술조사보고서",
        "receiptDate": "2017.11.30",
        "receiptNumber": "9-1-2017-0040286-11"
      },
      {
        "commonCodeName": "발송처리완료 (Completion of Transmission)",
        "documentEngName": "Notification of reason for refusal",
        "documentName": "의견제출통지서",
        "receiptDate": "2018.01.22",
        "receiptNumber": "9-5-2018-0049726-81"
      },
      {
        "commonCodeName": "수리 (Accepted)",
        "documentEngName": "[Designated Period Extension] Application of Period Extension(Reduction, Progress relief)",
        "documentName": "[지정기간연장]기간연장(단축, 경과구제)신청서",
        "receiptDate": "2018.03.22",
        "receiptNumber": "1-1-2018-0288967-14"
      },
      {
        "commonCodeName": "보정승인간주 (Regarded as an acceptance of amendment)",
        "documentEngName": "[Amendment to Description, etc.] Amendment",
        "documentName": "[명세서등 보정]보정서",
        "receiptDate": "2018.04.23",
        "receiptNumber": "1-1-2018-0404348-62"
      },
      {
        "commonCodeName": "수리 (Accepted)",
        "documentEngName": "[Opinion according to the Notification of Reasons for Refusal] Written Opinion(Written Reply, Written Substantiation)",
        "documentName": "[거절이유 등 통지에 따른 의견]의견(답변, 소명)서",
        "receiptDate": "2018.04.23",
        "receiptNumber": "1-1-2018-0404347-16"
      },
      {
        "commonCodeName": "발송처리완료 (Completion of Transmission)",
        "documentEngName": "Decision to Refuse a Patent",
        "documentName": "거절결정서",
        "receiptDate": "2018.05.31",
        "receiptNumber": "9-5-2018-0368816-30"
      },
      {
        "commonCodeName": "보정승인 (Acceptance of amendment)",
        "documentEngName": "Amendment to Description, etc(Reexamination)",
        "documentName": "[명세서등 보정]보정서(재심사)",
        "receiptDate": "2018.07.03",
        "receiptNumber": "1-1-2018-0656219-79"
      },
      {
        "commonCodeName": "수리 (Accepted)",
        "documentEngName": "[Opinion according to the Notification of Reasons for Refusal] Written Opinion(Written Reply, Written Substantiation)",
        "documentName": "[거절이유 등 통지에 따른 의견]의견(답변, 소명)서",
        "receiptDate": "2018.07.03",
        "receiptNumber": "1-1-2018-0656218-23"
      },
      {
        "commonCodeName": "발송처리완료 (Completion of Transmission)",
        "documentEngName": "Decision to Grant Registration",
        "documentName": "등록결정서",
        "receiptDate": "2018.07.06",
        "receiptNumber": "9-5-2018-0461006-80"
      }
    ]
  },
  "imagePathInfo": {
    "docName": "",
    "largePath": "",
    "path": ""
  },
  "rndInfoArray": {
    "rndInfo": [
      {
        "rndDepartmentName": "보건복지부",
        "rndDuration": "2015.06.01 ~ 2017.07.31",
        "rndManagingInstituteName": "국립암센터",
        "rndProjectName": "암연구소및국가암관리사업본부연구운영비지원",
        "rndSpecialInstituteName": "국립암센터",
        "rndTaskContribution": "40/100",
        "rndTaskName": "c-Myc 저해제 선도물질 최적화를 통한 전임상 및 임상 후보물질 개발",
        "rndTaskNumber": "1511220"
      },
      {
        "rndDepartmentName": "보건복지부",
        "rndDuration": "2015.01.01 ~ 2017.12.31",
        "rndManagingInstituteName": "국립암센터",
        "rndProjectName": "암연구소및국가암관리사업본부연구운영비지원",
        "rndSpecialInstituteName": "국립암센터",
        "rndTaskContribution": "20/100",
        "rndTaskName": "c-Myc 저해제를 이용한 방광암 치료제 개발",
        "rndTaskNumber": "1510130"
      },
      {
        "rndDepartmentName": "국립암센터",
        "rndDuration": "2015.06.01 ~ 2015.12.31",
        "rndManagingInstituteName": "한국화학연구원",
        "rndProjectName": "기타사업",
        "rndSpecialInstituteName": "국립암센터",
        "rndTaskContribution": "2/100",
        "rndTaskName": "(Action Proje ct)c-Myc저해제 선도물질 최적화를 통한전임상 및 임상후보물질 개발",
        "rndTaskNumber": "IK1506-H02"
      },
      {
        "rndDepartmentName": "국립암센터",
        "rndDuration": "2016.01.01 ~ 2016.12.31",
        "rndManagingInstituteName": "한국화학연구원",
        "rndProjectName": "기타사업",
        "rndSpecialInstituteName": "국립암센터",
        "rndTaskContribution": "20/100",
        "rndTaskName": "(Action Proje ct)c-Myc저해제 선도물질 최적화를 통한전임상 및 임상후보물질 개발",
        "rndTaskNumber": "IK1606-H02"
      },
      {
        "rndDepartmentName": "국립암센터",
        "rndDuration": "2017.01.01 ~ 2017.07.31",
        "rndManagingInstituteName": "한국화학연구원",
        "rndProjectName": "기타사업",
        "rndSpecialInstituteName": "국립암센터",
        "rndTaskContribution": "18/100",
        "rndTaskName": "(Action Proje ct)c-Myc저해제 선도물질 최적화를 통한전임상 및 임상후보물질 개발",
        "rndTaskNumber": "IK1706H02"
      }
    ]
  }
}